Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer

[Image: see text] The repertoire of methods for the detection and chemotherapeutic treatment of prostate cancer (PCa) is currently limited. Prostate-specific membrane antigen (PSMA) is overexpressed in PCa tumors and can be exploited for both imaging and drug delivery. We developed and characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenfeld, Lior, Sananes, Amiram, Zur, Yuval, Cohen, Shira, Dhara, Kalyan, Gelkop, Sigal, Ben Zeev, Efrat, Shahar, Anat, Lobel, Leslie, Akabayov, Barak, Arbely, Eyal, Papo, Niv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383930/
https://www.ncbi.nlm.nih.gov/pubmed/32442375
http://dx.doi.org/10.1021/acs.jmedchem.0c00418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383930/
https://www.ncbi.nlm.nih.gov/pubmed/32442375
http://dx.doi.org/10.1021/acs.jmedchem.0c00418

Ejemplares similares